Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk.
Maria Antonella ZingaropoliPatrizia PasculliMatteo TartagliaFederica DominelliFederica CicconeAmbra TagliettiValentina PerriLeonardo MalimpensaGina FerrazzanoMarco IannettaCosmo Del BorgoMiriam LichtnerClaudio Maria MastroianniAntonella ConteMaria Rosa CiardiPublished in: Biology (2023)
BAFF may have a role as a marker of immune dysfunction and of infectious risk.
Keyphrases